Background on Kimberly-Clark and Kenvue
Kimberly-Clark de México, a subsidiary of Kimberly-Clark Corporation, is a multinational personal care products company with 47.9% ownership in Kimberly-Clark de México. The company produces hygiene and personal care items, including Pétalo, Cotonelle, Evenflo, Huggies, Kleenex, Escudo, and Kotex brands.
Kimberly-Clark’s Acquisition of Kenvue
On November 3, 2025, Kimberly-Clark Corporation agreed to acquire Kenvue for $48.7 billion, with the transaction expected to close in the second half of 2026. Kenvue owns popular brands such as Listerine, Lubriderm, Neutrogena, and Tylenol, generating approximately $200 million in annual sales in Mexico.
Impact on Kimberly-Clark de México
The integration of Kenvue’s business in Mexico would add value to Kimberly-Clark de México by expanding into health and wellness categories. Pablo González Guajardo, Kimberly-Clark de México’s CEO, mentioned during a recent earnings call that they have initiated discussions with their strategic partner to determine the scope of this potential operation.
Potential Benefits
- Growth Opportunities: González highlighted that this integration presents a good opportunity for future growth, adding valuable categories to their portfolio.
- Increased Sales and Profitability: He expects this integration to contribute to sales growth, improved results, and better profit margins in the medium term.
- Strategic Focus: Kimberly-Clark de México aims to maintain or expand its presence in high-growth categories that offer value to consumers and business partners.
Kenvue’s Mexican Market Significance
With the acquisition, the combined company is projected to become one of the world’s largest health and wellness businesses, generating approximately $32 billion in annual revenue. Mexico would be the second-largest market for this combined entity, following the United States, with projected annual sales of around $3.8 billion.
Next Steps
González stated that they have just begun discussions with their strategic partner and anticipate having a clearer understanding of the potential integration by April, when they present first-quarter 2026 results.
